Compare BWMN & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BWMN | BBNX |
|---|---|---|
| Founded | 1995 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 579.7M | 1.2B |
| IPO Year | 2021 | 2025 |
| Metric | BWMN | BBNX |
|---|---|---|
| Price | $36.27 | $29.89 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 11 |
| Target Price | ★ $41.13 | $28.09 |
| AVG Volume (30 Days) | 130.6K | ★ 672.2K |
| Earning Date | 11-05-2025 | 10-28-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.94 | N/A |
| Revenue | ★ $474,277,000.00 | $88,570,000.00 |
| Revenue This Year | $16.97 | $52.13 |
| Revenue Next Year | $5.00 | $36.16 |
| P/E Ratio | $38.99 | ★ N/A |
| Revenue Growth | 16.73 | ★ 67.01 |
| 52 Week Low | $17.90 | $8.89 |
| 52 Week High | $45.83 | $32.71 |
| Indicator | BWMN | BBNX |
|---|---|---|
| Relative Strength Index (RSI) | 51.39 | 57.16 |
| Support Level | $33.15 | $28.00 |
| Resistance Level | $36.39 | $31.51 |
| Average True Range (ATR) | 1.64 | 1.88 |
| MACD | 0.47 | -0.29 |
| Stochastic Oscillator | 81.38 | 40.50 |
Bowman Consulting Group Ltd is a professional services firm delivering engineering solutions to customers who own, develop, and maintain the built environment. It provides planning, engineering, construction management, commissioning, environmental consulting, geospatial, survey, land procurement, and other technical services to customers operating in a diverse set of end markets. Its services include Civil & Site Engineering, Transportation Engineering, MEP Engineering, Commissioning & Energy Efficiency, Energy Services, Water/Wastewater, Fire Protection, Construction Management, Survey/Geospatial, Environmental Consulting, Structural Engineering, Land Procurement & Right-of-Way, Landscape and Architecture/Planning.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.